Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex for pain due to diabetic neuropathy
2004-002530-20Phase 3Completed
- Sponsor
- GW Pharmaceuticals
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic neuropathy comparing Sativex with Placebo (2 arms). Primary endpoint: Mean diabetic neuropathy pain score at end of treatment. Started Feb 2005; status: completed.
02
Drugs
cannabidiol
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on 2004-002530-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002530-20.